Introducing RaDaR ST for MRD testing Learn more

NEO AML Express

  • Next Generation Sequencing (NGS)
The NEO | AML Express assay is a next-generation sequencing (NGS) assay using combined DNA- and RNA-sequencing, which is used to identify prognostically and diagnostically informative alterations in acute myeloid leukemia (AML). The DNA sequencing component of this assay detects single nucleotide variants (SNVs) and indels in genes recurrently mutated in AML, and the RNA sequencing component detects fusions involving genes that are frequently involved in structural rearrangements observed in AML, as noted below. Test reports include summary interpretation of all results to help guide treatment decisions.
Turnaround time
5 Days

Level of Service

  • Global
New York Approved: Yes

Clinical Significance

In conjunction with clinical features and other laboratory results, molecular profiling with the NEO Express AML panel may facilitate risk stratification and therapy selection for patients with newly diagnosed AML.

Specimen Requirements

Bone Marrow Aspirate: 1-2 mL in EDTA tube.
Peripheral Blood: 2-3 mL in EDTA tube.
Note on fresh samples: NeoGenomics should receive within 7 days from collection for acceptable cell viability.

Storage and Transportation

Refrigerate specimen. Do not freeze. Use cold pack for transport, making sure cold pack is not in direct contact with specimen.
Note: To ensure fast TAT and sample stability, ship samples directly to NeoGenomics Houston (non-NY samples) or Ramsey (NY samples).

CPT Code(s)*

Client-Bill Only

*The CPT codes provided with our test descriptions are based on AMA guidelines and are for informational purposes only. Correct CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payor being billed.

Biomarkers

DNA Sequencing
SNVs + Indels
ABL1ASXL1BCORBRAFCALRCBL
CEBPACSF3RDDX41DNMT3AETV6EZH2
FLT3GATA2HRASIDH1IDH2JAK2
KITKRASMPLNF1NPM1NRAS
PHF6PPM1DPRPF8PTPN11RUNX1SETBP1
SF3B1SRSF2STAG2TET2TP53U2AF1
WT1ZRSR2
RNA Sequencing
Fusions
ABL1KAT6AKMT2AMECOMMYH11NUP214
NUP98RARARUNX1

Last Updated: March 02, 2026

Get in touch

Our Client Services team is on hand to help. Please call us at 866.776.5907, Option 3.